New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells

Journal of Cellular Physiology

Volumn 217, Issue 3, 2008, Pages 739-744

  Delassus, Gregory S ^a   Cho, Hyojin ^a   Park, Janice ^a   Eliceiri, George L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FIBULIN; FIBULIN 1D; GELATINASE A; GELATINASE B; INTERLEUKIN 4; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP2ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL INVASION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST TUMOR; DISEASE COURSE; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 54049100011     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21548     Document Type: Article

References (59)

1. Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JS. 2002. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene 21:87-95.
2. Bakalova R, Zhelev Z, Ohba H, Baba Y. 2005. Quantum dot-based western blot technology for ultrasensitive detection of tracer proteins. J Am Chem Soc 127:9328-9329.
3. Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW, Tainsky MA. 1993. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 13:4174-4185.
4. Cai XM, Tao BB, Wang LY, Liang YL, Jin JW, Yang Y, Hu YL, Zha XL. 2005. Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Int J Cancer 117:905-912.
5. Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, Kuo ML. 2007. CTGF enhances the motility of breast cancer cells via an integrin-{alpha}vbeta3-ERK1/2-dependent S100A4-upregulated pathway. J Cell Sci 120:2053-2065.
6. Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig R, Yung WK, Sawaya R, Kyritsis AP, Rao JS. 1997. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene 15:2049-2057.
7. Cybulski C, Masojc B, Oszutowska D, Jaworowska E, Grodzki T, Waloszczyk P, Serwatowski P, Pankowski J, Huzarski T, Byrski T, Gorski B, Jakubowska A, Debniak T, Wokolorczyk D, Gronwald J, Tarnowska C, Lubinski J, Narod SA. 2008. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. Carcinogenesis 29:762-765.
8. Davies BR, Barraclough R, Rudland PS. 1994. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines. Cancer Res 54:2785-2793.
9. Deryugina EI, Quigley JP. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9-34.
10. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. 1995. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886.
11. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
12. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185.
13. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-889.
14. Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, Frierson HF, Theodorescu D. 2004. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23:6788-6797.
15. Gottardi CJ, Wong E, Gumbiner BM. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153:1049-1060.
16. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H. 1998. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 75:654-658.
17. Hegedüs L, Cho H, Xie X, Eliceiri G. 2008. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. J Cell Physiol 216:480-485.
18. Hjelmeland AB, Hjelmeland MD, Shi Q, Hart JL, Bigner DD, Wang XF, Kontos CD, Rich JN. 2005. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. Cancer Res 65:11276-11281.
19. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ. 2001. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem 276:38830-38836.
20. Jee BK, Park KM, Surendran S, Lee WK, Han CW, Kim YS, Lim Y. 2006. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun 342:655-661.
21. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. 2005. Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019.
22. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE. 2006. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17:583-590.
23. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK. 2001. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20:6669-6678.
24. Lee JH, Seo YW, Park SR, Kim YJ, Kim KK. 2003. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 63:7147-7255.
25. Leonardi A, Cortivo R, Fregona I, Plebani M, Secchi AG, Abatangelo G. 2003. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Invest Ophthalmol Vis Sci 44:183-189.
26. Lu W, Zhou X, Hong B, Liu J, Yue Z. 2004. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene. Cancer Lett 214:205-213.
27. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS. 2006. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4:437-447.
28. Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP. 2006. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25:2379-2392.
29. Nawrocki-Raby B, Gilles C, Polette M, Bruyneel E, Laronze JY, Bonnet N, Foidart JM, Mareel M, Birembaut P. 2003. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 105:790-795.
30. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527.
31. Oh J-H, Kim A, Park J-M, Kim S-H, Chung A-S. 2006. Ultraviolet B-induced matrix metalloproteinase-1 and -3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts. J Cell Physiol 209:775-785.
32. Park MJ, Kwak HJ, Lee HC, Yoo DH, Park IC, Kim MS, Lee SH, Rhee CH, Hong SI. 2007. Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. J Biol Chem 282:30485-30496.
33. Pérez-Ruiz M, Collao X, Navarro-Mari JM, Tenorio A. 2007. Reverse transcription, real-time PCR assay for detection of Toscana virus. J Clin Virol 39:276-281.
34. Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. 2004. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 49:179-186.
35. Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, McCormick JJ. 1997. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15:2159-2168.
36. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274:13066-13076.
37. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin HB, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V, Mukhtar H. 2006. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci 103:14825-14830.
38. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. 2004. Reduction in raf kinase inhibitor protein expression is associated with increased ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186-5192.
39. Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M. 2007. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 26:4049-4058.
40. Senolt L, Grigorian M, Lukanidin E, Simmen B, Michel BA, Pavelka K, Gay RE, Gay S, Neidhart M. 2006. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis 65:1645-1648.
41. Sridhar SC, Miranti CK. 2006. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 25:2367-2378.
42. Sumigama S, Ito T, Kajiyama H, Shibata K, Tamakoshi K, Kikkawa F, Williams T, Tainsky MA, Nomura S, Mizutani S. 2004. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha. Oncogene 23:5496-5504.
43. Tamura M, Gu J, Takino T, Yamada KM. 1999. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59:442-449.
44. Tardif G, Pelletier J-P, Dupuis M, Geng C, Cloutier J-M, Martel-Pelletier J. 1999. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. Arthritis Rheum 42:1147-1158.
45. Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, Okagawa H, Sugi Y, Argraves WS. 2001. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114:4587-4598.
46. Uchiyama A, Essner R, Doi F, Nguyen T, Ramming KP, Nakamura T, Morton DL, Hoon DSB. 1996. Interleukin 4 inhibits hepatocyte growth factor-induced invasion andmigration of colon carcinomas. J Cell Biochem 62:443-453.
47. Uozumi M, Murao S, Katayama N, Kitazawa S, Amatsu M, Maeda S. 2000. Induction of S100A4 gene expression inhibits in vitro invasiveness of human squamous cell carcinoma, KOSC-3 cells. Cancer Lett 149:135-141.
48. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799.
49. Walsh T, King MC. 2007. Ten genes for inherited breast cancer. Cancer Cell 11:103-105.
50. Wang W, Eddy R, Condeelis J. 2007. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7:429-440.
51. Wong AS, Gumbiner BM. 2003. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161:1191-1203.
52. Wu X, Obata T, Khan Q, Highshaw RA, De Vere WR, Sweeney C. 2004. The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int 93:143-150.
53. Wyatt CA, Geoghegan JC, Brinckerhoff CE. 2005. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: Effects on matrix destruction and tumor growth. Cancer Res 65:11101-11108.
54. Xu Y, Yu Q. 2003. E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis. J Biol Chem 278:8661-8668.
55. Xu L, Peng H, Glasson S, Lee PL, Hu K, Ijiri K, Olsen BR, Goldring MB, Li Y. 2007. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum 56:2663-2673.
56. Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME. 2001. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61:5284-5288.
57. Yokota T, Otsuka T, Mosmann T, Banchereau J, DeFrance T, Blanchard D, Vries JED, Lee F, Arai KI. 1986. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci 83:5894-5898.
58. Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y. 2003. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int 53:659-666.
59. Zhou B, Liu L, Reddivari M, Zhang XA. 2004. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res 64:7455-7463.